166 related articles for article (PubMed ID: 30904494)
1. Structural insights on druggable hotspots in CD147: A bull's eye view.
Kumar D; Vetrivel U; Parameswaran S; Subramanian KK
Life Sci; 2019 May; 224():76-87. PubMed ID: 30904494
[TBL] [Abstract][Full Text] [Related]
2. Role of CD147 (EMMPRIN/Basigin) in Tissue Remodeling.
Guindolet D; Gabison EE
Anat Rec (Hoboken); 2020 Jun; 303(6):1584-1589. PubMed ID: 30768865
[TBL] [Abstract][Full Text] [Related]
3. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
[TBL] [Abstract][Full Text] [Related]
4. How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity.
Grass GD; Toole BP
Biosci Rep; 2015 Nov; 36(1):e00283. PubMed ID: 26604323
[TBL] [Abstract][Full Text] [Related]
5. CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.
Xin X; Zeng X; Gu H; Li M; Tan H; Jin Z; Hua T; Shi R; Wang H
Sci Rep; 2016 Sep; 6():32804. PubMed ID: 27608940
[TBL] [Abstract][Full Text] [Related]
6. Biological Characteristics of Cluster of Differentiation 147 and Its Relationship with Tumour.
Gao C; Lu CH; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):589-593. PubMed ID: 27825419
[TBL] [Abstract][Full Text] [Related]
7. Importance of N-glycosylation on CD147 for its biological functions.
Bai Y; Huang W; Ma LT; Jiang JL; Chen ZN
Int J Mol Sci; 2014 Apr; 15(4):6356-77. PubMed ID: 24739808
[TBL] [Abstract][Full Text] [Related]
8. The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.
Xiong L; Edwards CK; Zhou L
Int J Mol Sci; 2014 Sep; 15(10):17411-41. PubMed ID: 25268615
[TBL] [Abstract][Full Text] [Related]
9. CD147 immunoglobulin superfamily receptor function and role in pathology.
Iacono KT; Brown AL; Greene MI; Saouaf SJ
Exp Mol Pathol; 2007 Dec; 83(3):283-95. PubMed ID: 17945211
[TBL] [Abstract][Full Text] [Related]
10. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer.
Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y
Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy.
Wu B; Cui J; Yang XM; Liu ZY; Song F; Li L; Jiang JL; Chen ZN
Cell Death Dis; 2017 Jul; 8(7):e2925. PubMed ID: 28703811
[TBL] [Abstract][Full Text] [Related]
12. Dealing with the family: CD147 interactions with cyclophilins.
Yurchenko V; Constant S; Bukrinsky M
Immunology; 2006 Mar; 117(3):301-9. PubMed ID: 16476049
[TBL] [Abstract][Full Text] [Related]
13. Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts.
Abraham D; Zins K; Sioud M; Lucas T; Aharinejad S
Front Biosci; 2008 May; 13():5571-9. PubMed ID: 18508606
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
von Ungern-Sternberg SNI; Zernecke A; Seizer P
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419744
[TBL] [Abstract][Full Text] [Related]
15. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.
Li X; Yu X; Dai D; Song X; Xu W
Oncotarget; 2016 Apr; 7(17):23141-55. PubMed ID: 27009812
[TBL] [Abstract][Full Text] [Related]
16. CD147: a novel modulator of inflammatory and immune disorders.
Zhu X; Song Z; Zhang S; Nanda A; Li G
Curr Med Chem; 2014; 21(19):2138-45. PubMed ID: 24372217
[TBL] [Abstract][Full Text] [Related]
17. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.
Huang X; Shen W; Xi H; Zhang K; Cui J; Wei B; Chen L
Oncotarget; 2016 Dec; 7(49):81003-81011. PubMed ID: 27768590
[TBL] [Abstract][Full Text] [Related]
19. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
[TBL] [Abstract][Full Text] [Related]
20. CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.
Kosugi T; Maeda K; Sato W; Maruyama S; Kadomatsu K
Nephrol Dial Transplant; 2015 Jul; 30(7):1097-103. PubMed ID: 25248362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
